Randomized phase II study of CPT-11 plus mitomycin C versus oxaliplatin plus mitomycin C in previously treated patients with advanced colorectal cancer (ACC)
暂无分享,去创建一个
W. Scheithauer | W. Kwasny | G. Kornek | K. Haider | D. Depisch | W. Fiebiger | F. Lang | E. Kovats | S. Brugger | H. Ulrich‐Pur